Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Withdrawn × ixabepilone × Clear all

Phase

Phase 2 3 Phase 1/2 1 Phase 1 1

Status

Completed 19 Terminated 4 Unknown 2 Withdrawn 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Advanced Solid Tumors 1

Interventions

Cyclophosphamide 30 Radiotherapy 21 Cisplatin 21 fludarabine 19 Paclitaxel 17 Nivolumab 16 Magnetic Resonance Spectroscopy 16 fludarabine phosphate 14 Carboplatin 14 pembrolizumab 13 Specimen Handling 13 Gemcitabine 13 Radiation 11 Biopsy 11 Docetaxel 10 Melphalan 9 Filgrastim 9 Etoposide 9 Dexamethasone 9 Cytarabine 9 Radiosurgery 8 Granulocyte Colony-Stimulating Factor 8 Doxorubicin 8 venetoclax 7 trametinib 7 durvalumab 7 Sorafenib 7 Rituximab 7 Pemetrexed 7 Ipilimumab 7

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01170871 2014-05-21

Ixabepilone and Pemetrexed/Solid Tumors

University of Southern California

Phase 1 Withdrawn

Other solid neoplasm

Advanced Solid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡